LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
Minnesota MN
Legislatures
2025-2026 Regular Session
Senate
Bills
SF3271
MN
Minnesota Senate Bill SF3271
Minnesota 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
MN
Minnesota 2025-2026 Regular Session
Minnesota Senate Bill SF3271
Introduced
4/3/25
Refer
4/3/25
Caption
Independent audits of 340B entity reporting by nonprofit public interest organizations authorization; revenue from prescription drugs obtained under the 340B program to be used for charity care; enforcement by the attorney general authorization
Latest MN SF3271 Activity
View All Events: MN 2025-2026 Regular Session SF3271
Companion Bills
No companion bills found.
Previously Filed As
MN HB2081
Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program
MN HB2965
Covered entities; 340B drugs; distribution
MN H1527
Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs
MN H1281
Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs
MN SB1213
Enacts requirements for certain reporting regarding the federal 340B drug program
MN SB1178
Enacts requirements for certain reporting regarding the federal 340B drug program
MN S1638
Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs
MN SF3769
340B prescription drugs delivery restrictions prohibition
MN SB0118
340B drug program report.
MN HF3609
Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.
Similar Bills
No similar bills found.